Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study

Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the bes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Prostate cancer and prostatic diseases 2003-12, Vol.6 (4), p.311-314
Hauptverfasser: Ozveri, H, Cevik, I, Dillioglugil, O, Akdaş, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 314
container_issue 4
container_start_page 311
container_title Prostate cancer and prostatic diseases
container_volume 6
creator Ozveri, H
Cevik, I
Dillioglugil, O
Akdaş, A
description Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the best method of anesthesia, many studies, in which different methods were compared, have been performed. To determine the effectiveness of local injection anesthesia in TRUS-guided prostate biopsy, we designed and performed this prospective study in order to evaluate the utility of periprostatic nerve block for pain management. A total of 100 patients who had elevated total prostate-specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Half of the patients received periprostatic injection anesthesia (group I) and the remaining half received placebo (group II). Patients received 10 cm 3 (5 cm 3 each side) 1% lidocaine injected into the periprostatic nerve plexus under transrectal ultrasonic guidance. Pain during biopsy was assessed using a 10-point modified visual analog scale (VAS). In groups I and II, mean patient age was 66.8+2.5 and 65.6+11.5 y, mean tPSA was 7.87±3.6 and 11.3±1.7 ng/ml, mean biopsy duration was 6.5±2.5 and 6.6±2.2 min and mean pain score during TRUS-guided biopsy was 1.46±2.2 and 4.5±2.1, respectively. No statistically significant difference was observed with respect to age, tPSA and mean biopsy duration between these groups. Mean pain VAS score was statistically or significantly better ( P =0.0001) in the lidocaine injection group (group I), and furthermore no patient had a VAS pain score ≥5 in this group. Only minor and transient complications occurred in both groups. This study reinforces the usage of periprostatic nerve block as a standard method of pain management during TRUS-guided prostate biopsy, because it is simple, safe, uncostly and significantly effective without requiring additional time.
doi_str_mv 10.1038/sj.pcan.4500669
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2645319337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A189222540</galeid><sourcerecordid>A189222540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-903eb53dd2791d86c2be692fc8e7df46edc16c6d341f51f73c1fac7e1727d82c3</originalsourceid><addsrcrecordid>eNp1kk1r3DAQhk1oSdIk596KaKE3b_Qtu7cQkrYQ6CU9C600ysrYkmvZgf331XYXNoEGHSRGz_tqZjRV9ZHgFcGsuc7darQmrrjAWMr2pDonXMlaSNy8K2cmRa0aQc-qDzl3GOOWtPi0OiNcSsYVO6-Gx8nEPIGdTY9GmMI4pTybOVjUB5esCRFQiF0BQorIRMjzBnIwyKcJzS_FeyGgdUhj3n5D5l9o3CmfAeV5cdvL6r03fYarw35R_b6_e7z9UT_8-v7z9uahtrxRc91iBmvBnKOqJa6Rlq5BttTbBpTzXIKzRFrpGCdeEK-YJd5YBURR5Rpq2UX1Ze9bMvizlJR1l5Yplic1lVww0jKmCvX5TYq2WAjO5NHqyfSgQ_SpFG2HkK2-IU1LKRUcF2r1H6osB0OwKYIPJf5K8PWFYAOmnzc59cuuy_k1eL0HbWlm6bXX4xQGM201wXo3Azp3ejcD-jADRfHpUNayHsAd-cOnFwDvgVyu4hNMx7rf8vwLCVO-TQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229055436</pqid></control><display><type>article</type><title>Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ozveri, H ; Cevik, I ; Dillioglugil, O ; Akdaş, A</creator><creatorcontrib>Ozveri, H ; Cevik, I ; Dillioglugil, O ; Akdaş, A</creatorcontrib><description>Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the best method of anesthesia, many studies, in which different methods were compared, have been performed. To determine the effectiveness of local injection anesthesia in TRUS-guided prostate biopsy, we designed and performed this prospective study in order to evaluate the utility of periprostatic nerve block for pain management. A total of 100 patients who had elevated total prostate-specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Half of the patients received periprostatic injection anesthesia (group I) and the remaining half received placebo (group II). Patients received 10 cm 3 (5 cm 3 each side) 1% lidocaine injected into the periprostatic nerve plexus under transrectal ultrasonic guidance. Pain during biopsy was assessed using a 10-point modified visual analog scale (VAS). In groups I and II, mean patient age was 66.8+2.5 and 65.6+11.5 y, mean tPSA was 7.87±3.6 and 11.3±1.7 ng/ml, mean biopsy duration was 6.5±2.5 and 6.6±2.2 min and mean pain score during TRUS-guided biopsy was 1.46±2.2 and 4.5±2.1, respectively. No statistically significant difference was observed with respect to age, tPSA and mean biopsy duration between these groups. Mean pain VAS score was statistically or significantly better ( P =0.0001) in the lidocaine injection group (group I), and furthermore no patient had a VAS pain score ≥5 in this group. Only minor and transient complications occurred in both groups. This study reinforces the usage of periprostatic nerve block as a standard method of pain management during TRUS-guided prostate biopsy, because it is simple, safe, uncostly and significantly effective without requiring additional time.</description><identifier>ISSN: 1365-7852</identifier><identifier>EISSN: 1476-5608</identifier><identifier>DOI: 10.1038/sj.pcan.4500669</identifier><identifier>PMID: 14663473</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Aged ; Aged, 80 and over ; Anesthesia ; Anesthesia, Local - adverse effects ; Anesthetics ; Antigens ; Biomedical and Life Sciences ; Biomedicine ; Biopsy ; Biopsy - methods ; Cancer Research ; Care and treatment ; Case-Control Studies ; Complications ; Complications and side effects ; Diagnosis ; Dosage and administration ; Drug therapy ; Humans ; Injection ; Lidocaine ; Lidocaine - administration &amp; dosage ; Lidocaine - adverse effects ; Lidocaine - therapeutic use ; Male ; Middle Aged ; Nerves ; original-article ; Pain ; Pain - drug therapy ; Pain management ; Pain Measurement ; Pain, Postoperative ; Patients ; Prospective Studies ; Prostate ; Prostate cancer ; Prostate-specific antigen ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - diagnostic imaging ; Rectum - diagnostic imaging ; Statistical analysis ; Ultrasonography</subject><ispartof>Prostate cancer and prostatic diseases, 2003-12, Vol.6 (4), p.311-314</ispartof><rights>Springer Nature Limited 2003</rights><rights>COPYRIGHT 2003 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Dec 2003</rights><rights>Nature Publishing Group 2003.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-903eb53dd2791d86c2be692fc8e7df46edc16c6d341f51f73c1fac7e1727d82c3</citedby><cites>FETCH-LOGICAL-c487t-903eb53dd2791d86c2be692fc8e7df46edc16c6d341f51f73c1fac7e1727d82c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.pcan.4500669$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.pcan.4500669$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14663473$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ozveri, H</creatorcontrib><creatorcontrib>Cevik, I</creatorcontrib><creatorcontrib>Dillioglugil, O</creatorcontrib><creatorcontrib>Akdaş, A</creatorcontrib><title>Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study</title><title>Prostate cancer and prostatic diseases</title><addtitle>Prostate Cancer Prostatic Dis</addtitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><description>Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the best method of anesthesia, many studies, in which different methods were compared, have been performed. To determine the effectiveness of local injection anesthesia in TRUS-guided prostate biopsy, we designed and performed this prospective study in order to evaluate the utility of periprostatic nerve block for pain management. A total of 100 patients who had elevated total prostate-specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Half of the patients received periprostatic injection anesthesia (group I) and the remaining half received placebo (group II). Patients received 10 cm 3 (5 cm 3 each side) 1% lidocaine injected into the periprostatic nerve plexus under transrectal ultrasonic guidance. Pain during biopsy was assessed using a 10-point modified visual analog scale (VAS). In groups I and II, mean patient age was 66.8+2.5 and 65.6+11.5 y, mean tPSA was 7.87±3.6 and 11.3±1.7 ng/ml, mean biopsy duration was 6.5±2.5 and 6.6±2.2 min and mean pain score during TRUS-guided biopsy was 1.46±2.2 and 4.5±2.1, respectively. No statistically significant difference was observed with respect to age, tPSA and mean biopsy duration between these groups. Mean pain VAS score was statistically or significantly better ( P =0.0001) in the lidocaine injection group (group I), and furthermore no patient had a VAS pain score ≥5 in this group. Only minor and transient complications occurred in both groups. This study reinforces the usage of periprostatic nerve block as a standard method of pain management during TRUS-guided prostate biopsy, because it is simple, safe, uncostly and significantly effective without requiring additional time.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia</subject><subject>Anesthesia, Local - adverse effects</subject><subject>Anesthetics</subject><subject>Antigens</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biopsy</subject><subject>Biopsy - methods</subject><subject>Cancer Research</subject><subject>Care and treatment</subject><subject>Case-Control Studies</subject><subject>Complications</subject><subject>Complications and side effects</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Humans</subject><subject>Injection</subject><subject>Lidocaine</subject><subject>Lidocaine - administration &amp; dosage</subject><subject>Lidocaine - adverse effects</subject><subject>Lidocaine - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nerves</subject><subject>original-article</subject><subject>Pain</subject><subject>Pain - drug therapy</subject><subject>Pain management</subject><subject>Pain Measurement</subject><subject>Pain, Postoperative</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Prostate</subject><subject>Prostate cancer</subject><subject>Prostate-specific antigen</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - diagnostic imaging</subject><subject>Rectum - diagnostic imaging</subject><subject>Statistical analysis</subject><subject>Ultrasonography</subject><issn>1365-7852</issn><issn>1476-5608</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kk1r3DAQhk1oSdIk596KaKE3b_Qtu7cQkrYQ6CU9C600ysrYkmvZgf331XYXNoEGHSRGz_tqZjRV9ZHgFcGsuc7darQmrrjAWMr2pDonXMlaSNy8K2cmRa0aQc-qDzl3GOOWtPi0OiNcSsYVO6-Gx8nEPIGdTY9GmMI4pTybOVjUB5esCRFQiF0BQorIRMjzBnIwyKcJzS_FeyGgdUhj3n5D5l9o3CmfAeV5cdvL6r03fYarw35R_b6_e7z9UT_8-v7z9uahtrxRc91iBmvBnKOqJa6Rlq5BttTbBpTzXIKzRFrpGCdeEK-YJd5YBURR5Rpq2UX1Ze9bMvizlJR1l5Yplic1lVww0jKmCvX5TYq2WAjO5NHqyfSgQ_SpFG2HkK2-IU1LKRUcF2r1H6osB0OwKYIPJf5K8PWFYAOmnzc59cuuy_k1eL0HbWlm6bXX4xQGM201wXo3Azp3ejcD-jADRfHpUNayHsAd-cOnFwDvgVyu4hNMx7rf8vwLCVO-TQ</recordid><startdate>20031201</startdate><enddate>20031201</enddate><creator>Ozveri, H</creator><creator>Cevik, I</creator><creator>Dillioglugil, O</creator><creator>Akdaş, A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20031201</creationdate><title>Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study</title><author>Ozveri, H ; Cevik, I ; Dillioglugil, O ; Akdaş, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-903eb53dd2791d86c2be692fc8e7df46edc16c6d341f51f73c1fac7e1727d82c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia</topic><topic>Anesthesia, Local - adverse effects</topic><topic>Anesthetics</topic><topic>Antigens</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biopsy</topic><topic>Biopsy - methods</topic><topic>Cancer Research</topic><topic>Care and treatment</topic><topic>Case-Control Studies</topic><topic>Complications</topic><topic>Complications and side effects</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Humans</topic><topic>Injection</topic><topic>Lidocaine</topic><topic>Lidocaine - administration &amp; dosage</topic><topic>Lidocaine - adverse effects</topic><topic>Lidocaine - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nerves</topic><topic>original-article</topic><topic>Pain</topic><topic>Pain - drug therapy</topic><topic>Pain management</topic><topic>Pain Measurement</topic><topic>Pain, Postoperative</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Prostate</topic><topic>Prostate cancer</topic><topic>Prostate-specific antigen</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - diagnostic imaging</topic><topic>Rectum - diagnostic imaging</topic><topic>Statistical analysis</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ozveri, H</creatorcontrib><creatorcontrib>Cevik, I</creatorcontrib><creatorcontrib>Dillioglugil, O</creatorcontrib><creatorcontrib>Akdaş, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Prostate cancer and prostatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ozveri, H</au><au>Cevik, I</au><au>Dillioglugil, O</au><au>Akdaş, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study</atitle><jtitle>Prostate cancer and prostatic diseases</jtitle><stitle>Prostate Cancer Prostatic Dis</stitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><date>2003-12-01</date><risdate>2003</risdate><volume>6</volume><issue>4</issue><spage>311</spage><epage>314</epage><pages>311-314</pages><issn>1365-7852</issn><eissn>1476-5608</eissn><abstract>Transrectal ultrasound (TRUS)-guided biopsy remains the mainstay of the diagnosis of prostate cancer. Although this diagnostic method is a safe procedure and well tolerated by most patients a significant number of patients report discomfort and pain during prostate biopsy. In order to define the best method of anesthesia, many studies, in which different methods were compared, have been performed. To determine the effectiveness of local injection anesthesia in TRUS-guided prostate biopsy, we designed and performed this prospective study in order to evaluate the utility of periprostatic nerve block for pain management. A total of 100 patients who had elevated total prostate-specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Half of the patients received periprostatic injection anesthesia (group I) and the remaining half received placebo (group II). Patients received 10 cm 3 (5 cm 3 each side) 1% lidocaine injected into the periprostatic nerve plexus under transrectal ultrasonic guidance. Pain during biopsy was assessed using a 10-point modified visual analog scale (VAS). In groups I and II, mean patient age was 66.8+2.5 and 65.6+11.5 y, mean tPSA was 7.87±3.6 and 11.3±1.7 ng/ml, mean biopsy duration was 6.5±2.5 and 6.6±2.2 min and mean pain score during TRUS-guided biopsy was 1.46±2.2 and 4.5±2.1, respectively. No statistically significant difference was observed with respect to age, tPSA and mean biopsy duration between these groups. Mean pain VAS score was statistically or significantly better ( P =0.0001) in the lidocaine injection group (group I), and furthermore no patient had a VAS pain score ≥5 in this group. Only minor and transient complications occurred in both groups. This study reinforces the usage of periprostatic nerve block as a standard method of pain management during TRUS-guided prostate biopsy, because it is simple, safe, uncostly and significantly effective without requiring additional time.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>14663473</pmid><doi>10.1038/sj.pcan.4500669</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1365-7852
ispartof Prostate cancer and prostatic diseases, 2003-12, Vol.6 (4), p.311-314
issn 1365-7852
1476-5608
language eng
recordid cdi_proquest_journals_2645319337
source MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aged
Aged, 80 and over
Anesthesia
Anesthesia, Local - adverse effects
Anesthetics
Antigens
Biomedical and Life Sciences
Biomedicine
Biopsy
Biopsy - methods
Cancer Research
Care and treatment
Case-Control Studies
Complications
Complications and side effects
Diagnosis
Dosage and administration
Drug therapy
Humans
Injection
Lidocaine
Lidocaine - administration & dosage
Lidocaine - adverse effects
Lidocaine - therapeutic use
Male
Middle Aged
Nerves
original-article
Pain
Pain - drug therapy
Pain management
Pain Measurement
Pain, Postoperative
Patients
Prospective Studies
Prostate
Prostate cancer
Prostate-specific antigen
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - diagnostic imaging
Rectum - diagnostic imaging
Statistical analysis
Ultrasonography
title Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A00%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transrectal%20periprostatic%20lidocaine%20injection%20anesthesia%20for%20transrectal%20prostate%20biopsy:%20a%20prospective%20study&rft.jtitle=Prostate%20cancer%20and%20prostatic%20diseases&rft.au=Ozveri,%20H&rft.date=2003-12-01&rft.volume=6&rft.issue=4&rft.spage=311&rft.epage=314&rft.pages=311-314&rft.issn=1365-7852&rft.eissn=1476-5608&rft_id=info:doi/10.1038/sj.pcan.4500669&rft_dat=%3Cgale_proqu%3EA189222540%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229055436&rft_id=info:pmid/14663473&rft_galeid=A189222540&rfr_iscdi=true